The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.

CONCLUSION: This case describes the first reported concurrent DIIHA and DIIT due to TMP-SMX-induced antibodies in an HSCT patient. DIIHA and DIIT can present a diagnostic challenge in the setting of intermittent medication dosing.
PMID: 28905389 [PubMed - as supplied by publisher]

Source: Transfusion - September 14, 2017 Category: Hematology Authors: Linnik YA, Tsui EW, Martin IW, Szczepiorkowski ZM, Denomme GA, Gottschall JL, Hill JM, Dunbar NM Tags: Transfusion Source Type: research